Skip to main content
Premium Trial:

Request an Annual Quote

R Scott Greer, Amir Nashat

Premium
R Scott Greer has been appointed to the board of medical device maker Inogen.
 
Greer, who is managing director of venture capital firm Numenor Ventures, was previously chairman of Sirna Therapeutics, which was acquired by Merck earlier this year.
 

 
Polaris Venture Partners, a venture capital firm, has named Amir Nashat as a general partner focusing on seed, early-stage, and growth equity life science companies.
 
Among Polaris’ investments is Alnylam Pharmaceuticals.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.